It is commonly used but not limited to the treatment of heart conditions, diabetes, obesity, and certain cancers where they have been found to dysregulate miR-16, miR-145, MALAT-1, miR-155, miR-146a, miR-197, lncRNA SNHG7 and miR-223 (Piergentili et al., 2022). This evidence concerns the gene MALAT1 and diabetes mellitus.